Piloting an Innovation to Improve the Quality of Remote Abortion Services: Incorporating Use of Multi-Level Pregnancy Tests
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 165
- Locations
- 1
- Primary Endpoint
- Proportion of women who successfully receive the MLPTs
Study Overview
Brief Summary
Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services through enabling women to reliably ascertain their abortion outcomes at home sooner than would otherwise have been the case.
safe2choose provides remote medical abortion services through the Internet (information, counselling and access to abortion pills) in a growing number of countries worldwide. safe2choose will collaborate with Gynuity Health Projects to pilot the utility of MLPTs for home follow-up as part of its remote medical abortion services.
As safe2choose does not have a physical office, the location of the sponsor's office is listed in this entry as the study location. Women from the United States are NOT eligible to enroll.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- — to 50 Years (Child, Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Recipient of safe2choose medical abortion services
- •Able to read English or Spanish
- •≤ 56 days LMP
- •Willing and able to read and sign consent form
- •Agree to comply with the study procedures, including completing the follow-up survey
Exclusion Criteria
- •Does not meet inclusion criteria
Outcomes
Primary Outcomes
Proportion of women who successfully receive the MLPTs
Time Frame: 1 week after mailing the MLPTs
Proportion of women who use the MLPTs to determine their abortion outcome
Time Frame: 2 weeks after receiving medical abortion package
Proportion of women able to use MLPTs on their own without guidance or instruction from providers
Time Frame: 2 weeks after receiving medical abortion package
Proportion of women who take action based on the interpretation of their test results
Time Frame: 2 weeks after receiving medical abortion package
Proportion of women who are satisfied with using MLPTs
Time Frame: 2 weeks after receiving medical abortion package
Secondary Outcomes
- Proportion of all eligible safe2choose clients who elect to participate in the study(0 days after recruitment)
- Proportion of women who find the MLPT instructions (written and video) to be helpful tools(2 weeks after enrollment)